Patents by Inventor Taro Iwamoto

Taro Iwamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170258788
    Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
    Type: Application
    Filed: May 25, 2017
    Publication date: September 14, 2017
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Patent number: 9725125
    Abstract: A straddle-type vehicle which turns while a vehicle body is banked to a first side in a vehicle width direction around a predetermined angular displacement center, comprises a head lamp which irradiates a head lamp irradiation region set to be forward relative to the vehicle body; a first auxiliary lamp which irradiates a first auxiliary lamp irradiation region set to be forward relative to the head lamp irradiation region, in a region which is inward with respect to a turning direction; and a second auxiliary lamp which irradiates a second auxiliary lamp irradiation region set to be forward relative to the first auxiliary lamp irradiation region, in the region which is inward with respect to the turning direction, wherein a distance between the second auxiliary lamp and the angular displacement center is less than a distance between the first auxiliary lamp and the angular displacement center.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: August 8, 2017
    Assignee: Kawasaki Jukogyo Kabushiki Kaisha
    Inventors: Taro Iwamoto, Mikio Domoto
  • Publication number: 20170202833
    Abstract: Provided are an oral formulation capable of improving easy administrability and showing good preservation stability, and a substrate for oral formulation. An oral formulation containing a medicament; sugar alcohol; one or more kinds of hydrophilic polysaccharides selected from the group consisting of acacia, pullulan and maltodextrin; a gelling agent; and water, and a substrate for oral formulation, which contains sugar alcohol; the above-mentioned hydrophilic polysaccharides; a gelling agent; and water.
    Type: Application
    Filed: April 5, 2017
    Publication date: July 20, 2017
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Taro IWAMOTO, Nobuyuki KURAHASHI, Yoshikazu OKA, Chikako TAKEDA
  • Publication number: 20170190219
    Abstract: An agricultural tire according to an exemplary embodiment of the present invention is provided with plural lug blocks that are provided at a tread portion, and with protruding portions that protrude towards an outer side in a tire width direction from an end portion on the outer side in the tire width direction of the lug blocks, and that have a surface that, if an angle of a virtual straight line extending towards the outer side in the tire width direction is taken as 0°, faces a tire rotation direction at an angle of not less than 35° and not more than 55°.
    Type: Application
    Filed: April 1, 2015
    Publication date: July 6, 2017
    Applicant: BRIDGESTONE CORPORATION
    Inventor: Taro IWAMOTO
  • Patent number: 9694009
    Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: July 4, 2017
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Publication number: 20170182930
    Abstract: A vehicle comprises a head lamp which irradiates a head lamp irradiation region set in front of a vehicle body; an auxiliary lamp which irradiates an auxiliary lamp irradiation region set in front of the head lamp irradiation region; a bank state detecting section which detects a bank state of the vehicle body; and a lighting control section which lights the auxiliary lamp depending on the bank state, the lighting control section causes the auxiliary lamp to be lighted in a set lighting state when the bank state detecting section detects a predetermined set bank state, and the lighting control section causes the auxiliary lamp to be lighted in a preceding lighting state at luminosity lower than that of the set lighting state, when the bank state detecting section detects a preceding bank state which occurs before the vehicle body reaches the set bank state.
    Type: Application
    Filed: December 23, 2016
    Publication date: June 29, 2017
    Inventors: Takuya Sakamoto, Taro Iwamoto, Osamu Tani
  • Publication number: 20170182929
    Abstract: A vehicle which turns in a state in which a vehicle body is banked from an upright state to a first side in a vehicle width direction of the vehicle body, comprises a lamp which is attached to the vehicle body, and irradiates a lamp irradiation region set in front of the vehicle body; a detecting section which detects a change over time of a posture of the vehicle body while the vehicle is traveling; and a control section which controls the lamp in such a manner that the lamp irradiation region is changed based on the change over time of the posture of the vehicle body which is detected by the detecting section.
    Type: Application
    Filed: December 22, 2016
    Publication date: June 29, 2017
    Inventors: Takuya Sakamoto, Taro Iwamoto, Osamu Tani
  • Publication number: 20160310489
    Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
    Type: Application
    Filed: June 8, 2016
    Publication date: October 27, 2016
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Publication number: 20160314128
    Abstract: An information processing apparatus is configured to provide a result of a search according to a search input given via an input unit so as to provide, as the result of the search, information that matches registered user information associated with a particular registered user. The information processing apparatus includes a matching information search unit that retrieves information that matches the registered user information according to the search input, a matching level calculation unit that calculates a matching level, with respect to the registered user information, of the information obtained as the result of the search performed by the matching information search unit, and a search result providing unit that provides, together with the result of the search, the matching level with respect to the registered user information calculated by the matching level calculation unit.
    Type: Application
    Filed: April 5, 2016
    Publication date: October 27, 2016
    Applicant: Alpine Electronics, Inc.
    Inventors: Hidetoshi Kadoya, Wataru Oikubo, Taro Iwamoto, Kiyozumi Fujiwara
  • Patent number: 9387182
    Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: July 12, 2016
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Publication number: 20160185409
    Abstract: A straddle-type vehicle which turns while a vehicle body is banked to a first side in a vehicle width direction around a predetermined angular displacement center, comprises a head lamp which irradiates a head lamp irradiation region set to be forward relative to the vehicle body; a first auxiliary lamp which irradiates a first auxiliary lamp irradiation region set to be forward relative to the head lamp irradiation region, in a region which is inward with respect to a turning direction; and a second auxiliary lamp which irradiates a second auxiliary lamp irradiation region set to be forward relative to the first auxiliary lamp irradiation region, in the region which is inward with respect to the turning direction, wherein a distance between the second auxiliary lamp and the angular displacement center is less than a distance between the first auxiliary lamp and the angular displacement center.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 30, 2016
    Inventors: Taro Iwamoto, Mikio Domoto
  • Publication number: 20160030423
    Abstract: The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-serotonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamazapine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder.
    Type: Application
    Filed: July 10, 2015
    Publication date: February 4, 2016
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Patent number: 9125939
    Abstract: The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-sero-tonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamaza-pine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: September 8, 2015
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Publication number: 20150126521
    Abstract: Provided are an oral formulation capable of improving easy administrability and showing good preservation stability, and a substrate for oral formulation. An oral formulation containing a medicament; sugar alcohol; one or more kinds of hydrophilic polysaccharides selected from the group consisting of acacia, pullulan and maltodextrin; a gelling agent; and water, and a substrate for oral formulation, which contains sugar alcohol; the above-mentioned hydrophilic polysaccharides; a gelling agent; and water.
    Type: Application
    Filed: April 30, 2013
    Publication date: May 7, 2015
    Inventors: Taro Iwamoto, Nobuyuki Kurahashi, Yoshikazu Oka, Chikako Takeda
  • Publication number: 20140221388
    Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
    Type: Application
    Filed: April 15, 2014
    Publication date: August 7, 2014
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Tetsuro KIKUCHI, Taro IWAMOTO, Tsuyoshi HIROSE
  • Patent number: 8759350
    Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
    Type: Grant
    Filed: December 25, 2003
    Date of Patent: June 24, 2014
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Tetsuro Kikuchi, Taro Iwamoto, Tsuyoshi Hirose
  • Patent number: 8743150
    Abstract: A display processing device for displaying a display object in a display window and changing a display range includes a sectioning unit that divides the display window into a plurality of sections (screens) by creating boundary lines. Maps of geographical ranges to be displayed are sectioned and displayed in the plurality of screens. In the event that a boundary line is moved through a user input, the geographical ranges of the maps in the screens for which the screen size has become larger than an initial screen size are enlarged, and the maps in the screens which have become smaller than the initial screen size are reduced in scale in accordance with the reduction in screen size, while maintaining the geographical range of the maps displayed in the display window prior to the boundary line being moved.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: June 3, 2014
    Assignee: Alpine Electronics, Inc.
    Inventors: Taro Iwamoto, Akihiko Takizawa, Takeshi Kimoto, Mitsuhiro Yashiro, Makoto Nishiyama
  • Patent number: 8710974
    Abstract: A sound producing apparatus for a vehicle notifying a vehicle's approach outside the vehicle comprising an original-tone generating portion generating an original tone of a vehicle's approaching sound for recognition of a vehicle's approach, a modulation-tone generating portion generating a modulation tone from the original tone with a comb filter function which is configured to apply gains to frequency components so that a gain to be applied to a specified frequency component of a times-tone row which has frequencies of n-times of a fundamental frequency is greater than that to be applied to the other frequency component than the specified frequency component of the times-tone row, a sound-pressure setting portion setting a sound pressure of the approaching sound of the modulation tone, and a speaker producing outside the vehicle the vehicle's approaching sound of the modulation tone with the set sound pressure.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: April 29, 2014
    Assignee: Mazda Motor Corporation
    Inventor: Taro Iwamoto
  • Patent number: 8413700
    Abstract: A tire having a circumferential tread, at least one belt, an inner liner, a pair of sidewalls, and at least three carcass plies. The tire includes a pair of bead portions, each including a bead core, a bead filler, a flipper, a chafer, and a gum strip. The at least three carcass plies extend radially downward, inward of the bead filler, extend around the bead core, and continue upward, outward of the bead filler and terminate in at least three turn-up ends. At least one of the turn-up ends does not contact at least one of the radially downward extending carcass plies, the flipper, or the bead filler in one of the sidewalls, and at least two of the turn-up ends contact at least one of the radially downward extending carcass plies, the flipper, or the bead filler in one of the sidewalls.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 9, 2013
    Assignee: Bridgestone Americas Tire Operations, LLC
    Inventors: Todd A Buxton, Bradley J Harris, Taro Iwamoto, Christopher A Swartzwelder
  • Patent number: D698671
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: February 4, 2014
    Assignee: Alpine Electronics, Inc.
    Inventors: Shu Takahara, Taro Iwamoto